VREX logo

Varex Imaging Corporation (VREX)

Profile

Full Name

Varex Imaging Corporation

Ticker

NASDAQ: VREX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

January 23, 2017

Indexes

Not included

Website

https://www.vareximaging.com

Employees

2300

Key Details

Price

$10.24(-13.66%)

Market Cap

$425.17M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$844.60M(4.14% YoY)

Annual EPS

-$1.70(-45.41% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.24
    VREX price is $10.24

    30-Day Relative Volume

    3.51
    VREX 30-day relative volume is 3.51

    Price Performance

    Price Most Recent Change

    -13.66%
    VREX price was down -13.66% on Nov 19, 2025

    Price YTD Change

    -29.81%
    VREX price is down -29.81% since January 1st

    Price 1-Year Change

    -29.67%
    VREX price is down -29.67% year-on-year

    Price 3-Year Change

    -52.83%
    VREX price is down -52.83% over the past 3 years

    Price Range

    Price All-Time High

    $43.76
    VREX price is currently -76.60% below its historical high of $43.76

    Price 3-Year Low

    $6.76
    VREX price is currently +51.48% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $425.17M
    VREX market cap is $425.17 million

    Market Cap 3-Year Change

    -51.16%
    VREX market cap is down -51.16% over the past 3 years

    Market Cap All-Time High

    $1.64B
    VREX market cap is currently -74.07% below its historical high of $1.64 billion

    Market Cap Sector Percentile

    60.25%
    VREX market cap is higher than 60.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.02%
    VREX shares outstanding is up +1.02% year-on-year

    Shares Outstanding 3-Year Change

    +3.54%
    VREX shares outstanding is up +3.54% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.90
    VREX beta is 1.90

    200-day SMA

    $10.26
    VREX price is currently -0.21% below its 200-day simple moving average

    50-day SMA

    $11.82
    VREX price is currently -13.36% below its 50-day simple moving average

    14-Day RSI

    32.47
    VREX 14-day relative strength index is 32.47

    Volume

    3.51
    VREX 30-day relative volume is 3.51

    ATR

    $0.64
    VREX average true range is $0.64

    10-day Historical Volatility

    78.55%
    VREX 10-day historical volatility is 78.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $844.60M
    VREX annual revenue is $844.60 million

    Revenue Analysts Estimate

    $859.76M
    VREX annual revenue is currently -1.76% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +4.14%
    VREX annual revenue is up +4.14% year-on-year

    Revenue Sector Percentile

    84.86%
    VREX annual revenue is higher than 84.86% of companies in Healthcare sector

    EPS

    EPS

    -$1.70
    VREX annual earnings per share is -$1.70

    EPS Analysts Estimate

    $0.81
    VREX annual earnings per share is currently -311.18% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -45.41%
    VREX annual earnings per share is down -45.41% year-on-year

    EPS Sector Percentile

    41.73%
    VREX annual earnings per share is higher than 41.73% of companies in Healthcare sector

    Profit

    Gross Profit

    $290.50M
    VREX annual gross profit is $290.50 million

    Gross Margin

    34.39%
    VREX annual gross profit margin is 34.39%

    Operating Profit

    $66.10M
    VREX annual operating income is $66.10 million

    Operating Margin

    7.83%
    VREX annual operating profit margin is 7.83%

    Net Income

    -$70.30M
    VREX annual net profit is -$70.30 million

    Net Margin

    -
    VREX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $778.50M
    VREX annual total expenses is $778.50 million

    Operating Expenses

    $224.40M
    VREX annual total operating expenses is $224.40 million

    Cost Of Goods Sold

    $554.10M
    VREX annual cost of goods sold is $554.10 million

    Selling, General & Administrative Expenses

    $133.30M
    VREX annual SG&A is $133.30 million

    Depreciation & Amortization

    $27.20M
    VREX annual D&A is $27.20 million

    Interest Expense

    $32.70M
    VREX annual interest expense is $32.70 million

    Income Tax

    $10.70M
    VREX annual income tax is $10.70 million

    EBIT & EBITDA

    EBIT

    -$26.50M
    VREX annual earnings before interest & taxes is -$26.50 million

    EBITDA

    $97.60M
    VREX annual EBITDA is $97.60 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $1.11B
    VREX annual total assets is $1.11 billion

    Non Current Assets

    $465.60M
    VREX annual long term assets is $465.60 million

    Current Assets

    $641.80M
    VREX annual total current assets is $641.80 million

    Cash and Cash Equivalents

    $145.00M
    VREX annual cash & cash equivalents is $145.00 million

    Accounts Receivable

    $156.60M
    VREX annual accounts receivable is $156.60 million

    Inventory

    $299.40M
    VREX annual inventory is $299.40 million

    Liabilities

    Total Liabilities

    $620.80M
    VREX annual total liabilities is $620.80 million

    Long Term Liabilities

    $433.60M
    VREX annual total long term liabilities is $433.60 million

    Current Liabilities

    $187.20M
    VREX annual current liabilities is $187.20 million

    Accounts Payable

    $69.90M
    VREX annual accounts payable is $69.90 million

    Debt

    Total Debt

    $395.90M
    VREX annual total debt is $395.90 million

    Total Debt 1-Year Change

    -16.95%
    VREX annual total debt is down -16.95% year-on-year

    Long Term Debt

    $390.00M
    VREX annual long term debt is $390.00 million

    Short Term Debt

    $1.50M
    VREX annual short term debt is $1.50 million

    Equity & Capital

    Shareholders Equity

    $472.60M
    VREX annual stockholders equity is $472.60 million

    Book Value

    $260.20M
    VREX annual book value is $260.20 million

    Retained Earnings

    -$5.90M
    VREX annual retained earnings is -$5.90 million

    Working Capital

    $454.60M
    VREX annual working capital is $454.60 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $41.70M
    VREX annual cash from operations is $41.70 million

    Cash From Operations 1-Year Change

    -11.84%
    VREX annual cash from operations is down -11.84% year-on-year

    Cash From Investing

    $10.30M
    VREX annual cash from investing is $10.30 million

    Cash From Investing 1-Year Change

    +137.45%
    VREX annual cash from investing is up +137.45% year-on-year

    Cash From Financing

    -$75.90M
    VREX annual cash from financing is -$75.90 million

    Cash From Financing 1-Year Change

    -2200%
    VREX annual cash from financing is down -2200% year-on-year

    CAPEX

    CAPEX

    $22.90M
    VREX annual capital expenditures is $22.90 million

    CAPEX 1-Year Change

    -14.87%
    VREX annual capital expenditures is down -14.87% year-on-year

    Free Cash Flow

    Free Cash Flow

    $18.80M
    VREX annual free cash flow is $18.80 million

    Free Cash Flow 1-Year Change

    -7.84%
    VREX annual free cash flow is down -7.84% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    34.39%
    VREX annual gross profit margin is 34.39%

    Operating Margin

    7.83%
    VREX annual operating profit margin is 7.83%

    Net Margin

    -
    VREX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -6.35%
    VREX annual return on assets is -6.35%

    ROE

    -14.88%
    VREX annual return on equity is -14.88%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    VREX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    VREX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.63
    VREX price to book ratio is 1.63

    PB Ratio Sector Percentile

    47.73%
    VREX price to book ratio is higher than 47.73% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.50
    VREX price to sales ratio is 0.50

    PS Ratio Sector Percentile

    12.99%
    VREX price to sales ratio is higher than 12.99% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $676.07M
    VREX enterprise value is $676.07 million

    Enterprise Value Sector Percentile

    67.57%
    VREX enterprise value is higher than 67.57% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    182.72
    VREX EV/EBITDA is 182.72

    EV/EBITDA Sector Percentile

    99.19%
    VREX EV/EBITDA is higher than 99.19% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.43
    VREX annual current ratio is 3.43

    Quick Ratio

    1.83
    VREX annual quick ratio is 1.83

    Leverage

    Debt To Equity

    0.84
    VREX annual debt to equity ratio is 0.84

    Interest Coverage Ratio

    -0.81
    VREX annual interest coverage ratio is -0.81

    Risk & Stability

    F-Score

    6
    VREX piotroski f-score is 6

    Altman Z-Score

    1.66
    VREX altman z-score is 1.66

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 B. Riley Securities
    Buy
    Feb 7, 25 Oppenheimer
    Outperform
    Feb 7, 25 B. Riley Securities
    Buy
    Aug 23, 24 B. Riley Securities
    Buy
    Nov 15, 23 Oppenheimer
    Outperform
    Aug 2, 23 Oppenheimer
    Outperform
    May 24, 23 Jefferies
    Hold
    Oct 12, 22 Jefferies
    Hold
    Feb 5, 21 Oppenheimer
    Outperform
    Aug 13, 20 Oppenheimer
    Perform

    Institutional Ownership

    Screeners with VREX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Varex Imaging Corporation?
    • Does Varex Imaging Corporation pay dividends?
    • What sector is Varex Imaging Corporation in?
    • What industry is Varex Imaging Corporation in?
    • What country is Varex Imaging Corporation based in?
    • When did Varex Imaging Corporation go public?
    • Is Varex Imaging Corporation in the S&P 500?
    • Is Varex Imaging Corporation in the NASDAQ 100?
    • Is Varex Imaging Corporation in the Dow Jones?
    • When was Varex Imaging Corporation's last earnings report?
    • When does Varex Imaging Corporation report earnings?

    What is the ticker symbol for Varex Imaging Corporation?

    The ticker symbol for Varex Imaging Corporation is NASDAQ:VREX

    Does Varex Imaging Corporation pay dividends?

    No, Varex Imaging Corporation does not pay dividends

    What sector is Varex Imaging Corporation in?

    Varex Imaging Corporation is in the Healthcare sector

    What industry is Varex Imaging Corporation in?

    Varex Imaging Corporation is in the Medical Devices industry

    What country is Varex Imaging Corporation based in?

    Varex Imaging Corporation is headquartered in United States

    When did Varex Imaging Corporation go public?

    Varex Imaging Corporation's initial public offering (IPO) was on January 23, 2017

    Is Varex Imaging Corporation in the S&P 500?

    No, Varex Imaging Corporation is not included in the S&P 500 index

    Is Varex Imaging Corporation in the NASDAQ 100?

    No, Varex Imaging Corporation is not included in the NASDAQ 100 index

    Is Varex Imaging Corporation in the Dow Jones?

    No, Varex Imaging Corporation is not included in the Dow Jones index

    When was Varex Imaging Corporation's last earnings report?

    Varex Imaging Corporation's most recent earnings report was on November 18, 2025

    When does Varex Imaging Corporation report earnings?

    The date for Varex Imaging Corporation's next earnings report has not been announced yet
    On this page